Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Clement Opoku-Temeng Herman O. Sintim |
| Publication date | May 22, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |